RBC Capital Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 19 20:31 · Ratings

Perspective Therapeutics To Discuss Data On [212Pb]VMT-α-NET Presented At The 2024 NANETS Multidisciplinary NET Medical Symposium On November 21, 2024

BenzingaNov 16 05:10

Truist Financial Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 14 20:31 · Ratings

JonesTrading Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 14 00:32 · Ratings

Optimistic Outlook for Perspective Therapeutics Amid Promising Trial Developments

TipRanksNov 14 00:05

Oppenheimer Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 13 21:36 · Ratings